Hutchison China MediTech Limited Reports 2020 Full Year Results and Provides Business Updates and Evolves Corporate Identity

NEXT STORY
Apollomics, Inc. Announces Successful Enrollment of First Patient Into Phase 1 Clinical Trial of APL-106 (Uproleselan Injection) in China
PREV STORY
Sotherly Hotels Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunovaccine Announces Achievement of Milestones in Collaboration with Zoetis to Develop Veterinary Vaccines

HALIFAX, Nova Scotia, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

author_avatar
NASDAQ Market News

DrugCendR Announces Pancreatic Cancer Clinical Trial Data, New Member of Board of Directors and FDA Orphan Drug Designation

LA JOLLA, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- DrugCendR Inc., a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Momenta Pharmaceuticals Appoints Jose-Carlos Gutierrez-Ramos, Ph.D. to Board of Directors

CAMBRIDGE, Mass., March 09, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company ...

author_avatar
NASDAQ Market News